Fujitsu, the Japanese technology group, has launched an AI-driven platform that automates the entire software development lifecycle, from requirements definition through to integration testing.
The platform uses Fujitsu's proprietary Takane large language model (LLM) and agentic AI technology, which enables multiple AI agents to collaborate across each stage of development without human intervention.
The company says it will use the platform to update all 67 types of medical and government software products operated by its subsidiary Fujitsu Japan Limited by the end of fiscal year 2026, driven by legal and regulatory changes.
The platform has been deployed in Japan since January 2026 to handle software updates required by that year's medical fee revisions, a process that governs how healthcare providers are reimbursed under Japan's national insurance system.
In an earlier proof of concept tied to the 2024 medical fee revisions, one of roughly 300 change requests that took three person-months using conventional methods was completed in four hours with the platform, a claimed productivity increase of around 100 times.
Related reading
- monday.com is pushing AI incentives as partner program helps drive adoption
- AMD, Comcast and Classiq aim quantum algorithms at internet routing
- Glean: Developing middleware that makes chatbots useful
Fujitsu said it will pair the platform with what it calls AI-Ready Engineering, a preparatory process that organises existing system documentation and institutional knowledge so that AI agents can accurately interpret legacy infrastructure.
The company added it plans to expand its Forward Deployed Engineer team, a role focused on embedding technical staff directly within customer operations, and said it intends to shift from charging clients based on person-months of labour to a model tied to the value delivered to customers.The Recap
- Fujitsu launched an AI-driven platform to automate software lifecycle.
- Platform will modify 67 Fujitsu Japan software products.
- Revisions to all products targeted by end of fiscal year 2026.
